Clinical Trial Update: A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC) [Phase 2]

View source ↗

Summary

Phase 2 pilot study evaluating combined immune checkpoint inhibition with ablative therapies in hepatocellular carcinoma and biliary tract carcinomas; trial com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bile Duct Cancer
• Biliary Tract Neoplasms
• Cholangiocarcinoma
• Hepatocellular Carcinoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Biliary Tract Neoplasms, Liver Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-03-24